BRIEF-Theon International Enters Exclusivity Agreement To Buy HGH For €300 Mln Enterprise Value

June 17 (Reuters) - Theon International Plc THEON.AS:

  • THEON INTERNATIONAL - ENTERS EXCLUSIVITY AGREEMENT TO BUY HGH FOR €300 MILLION ENTERPRISE VALUE

  • THEON INTERNATIONAL: DEAL WILL BE FINANCED WITH BRIDGE FACILITY PROVIDED BY BNP PARIBAS, INTENDED TO BE FULLY REFINANCED WITH DEBT

  • THEON INTERNATIONAL: DEAL EXPECTED TO BE EBITDA MARGIN ACCRETIVE, MID-SINGLE-DIGIT EPS ACCRETIVE IN 2027

Source text: ID:nGNX8c5XV2

Further company coverage: THEON.AS


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.